Literature DB >> 17364367

Juvenile nasopharyngeal angiofibromas in Denmark 1981-2003: diagnosis, incidence, and treatment.

H Glad1, B Vainer, C Buchwald, B L Petersen, S A Theilgaard, P Bonvin, C Lajer, J Jakobsen.   

Abstract

CONCLUSIONS: Juvenile nasopharyngeal angiofibroma (JNA) is a rare tumor in young males, with a non-negligible potential for recurrence. Preoperative embolization is a safe procedure that diminishes the peroperative blood loss and the need for blood transfusion. The endoscopic approach was used with good results in JNA stage I and II (Chandler).
OBJECTIVES: To estimate the incidence rate of JNA in the Danish population and to describe symptoms and treatment. PATIENTS AND METHODS: This was a national retrospective cohort study. All cases of JNA diagnosed in Denmark from 1981 to 2003 were identified. Data were extracted from medical records.
RESULTS: Forty-five male (no female) JNA cases were identified. In 43 cases, clinical data were recovered. Median age was 15 years. The incidence rate in Denmark was 0.4 cases per million inhabitants per year and 3.7 cases per million males (aged 10-24) per year. All patients underwent surgery, and the endoscopic approach was increasingly being used. The embolization procedure proved to be safe and decreased the intraoperative blood loss statistically to 650 ml in the embolized group from an average of 1200 ml in the non-embolized group (p<0.05). Similarly, the need for peroperative blood transfusion was reduced (p<0.005). The primary recurrence rate was 23% and no patients died.

Entities:  

Mesh:

Year:  2007        PMID: 17364367     DOI: 10.1080/00016480600818138

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  13 in total

Review 1.  Juvenile Angiofibroma: Current Management Strategies.

Authors:  Ahmad Safadi; Alberto Schreiber; Dan M Fliss; Piero Nicolai
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-18

2.  Cumulative sum analysis of the learning curve for endoscopic resection of juvenile nasopharyngeal angiofibroma.

Authors:  Xiaole Song; Dehui Wang; Xicai Sun; Jingjing Wang; Zhuofu Liu; Quan Liu; Yurong Gu
Journal:  Surg Endosc       Date:  2018-01-24       Impact factor: 4.584

3. 

Authors:  Tyler Yan; Ran D Goldman
Journal:  Can Fam Physician       Date:  2021-06       Impact factor: 3.275

4.  The changing surgical management of juvenile nasopharyngeal angiofibroma.

Authors:  Suvi Renkonen; Jaana Hagström; Jyrki Vuola; Mika Niemelä; Matti Porras; Sanna-Maria Kivivuori; Ilmo Leivo; Antti A Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-17       Impact factor: 2.503

Review 5.  Endoscopic treatment of juvenile nasopharyngeal angiofibromas: our experience and review of the literature.

Authors:  G Fyrmpas; I Konstantinidis; J Constantinidis
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-26       Impact factor: 2.503

6.  Clinicopathological profile of benign soft tissue tumours: a study in a tertiary care hospital in Western India.

Authors:  Bharti G Ramnani; Ashutosh Kumar; Shruti Chandak; Amar Ranjan; Mehul Kumar Patel
Journal:  J Clin Diagn Res       Date:  2014-10-20

7.  Recurrent epistaxis in children.

Authors:  Tyler Yan; Ran D Goldman
Journal:  Can Fam Physician       Date:  2021-06       Impact factor: 3.275

8.  Management and Outcome in Patients with Advanced Juvenile Nasopharyngeal Angiofibroma.

Authors:  Vedantam Rupa; Sunithi Elizabeth Mani; Selvamani Backianathan; Vedantam Rajshekhar
Journal:  J Neurol Surg B Skull Base       Date:  2017-11-27

9.  Association between vascular supply, stage and tumour size of juvenile nasopharyngeal angiofibroma.

Authors:  Raghav Mehan; V Rupa; Vijay Kumar Lukka; Munawar Ahmed; Vinu Moses; N K Shyam Kumar
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-11       Impact factor: 2.503

Review 10.  Soft Tissue Special Issue: Fibroblastic and Myofibroblastic Neoplasms of the Head and Neck.

Authors:  Esther Baranov; Jason L Hornick
Journal:  Head Neck Pathol       Date:  2020-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.